Home Science & Medicine

Science & Medicine

Feature articles about advances and current developments in science and medicine that have significant impact or impact potential on thoracic oncology.

Latest

Expanding Efforts Help Address Disparities in Lung Cancer Care

lungcanc

SHAWL: Largest Study of Its Kind Evaluates Sexual Dysfunction in Women With Lung Cancer

Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in NSCLC

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data

Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration...

lungcanc

Sustained Funding Vital for Smoking-Cessation Efforts

lungcanc

Telehealth: Bridging the Digital Divide Is Still a Work In Progress

lungcanc

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

lungcanc

An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in...

lungcanc

Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

lungcanc

Bringing Telehealth to the Front Lines of Lung Cancer Care in...

lungcanc

Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer...

lungcanc

Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy

lungcanc

Building and Maintaining a Patient–Physician Relationship in the COVID-19 Era

lungcanc

12 3...24 Page 1 of 24

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib